We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Remedy Informatics, Inc. has announced a new biorepository informatics software, SpecimenTrack(TM).  At the core of SpecimenTrack is intuitive management of biorepository workflows in sample collection, inventory, processing, and distribution with particular emphasis on saving time through reduced complexity and ease of use with a modern, web-based application that facilitates collaboration. To keep pace with changing biorepository informatics needs, SpecimenTrack has configurable sample types, storage containers, and workflow automation templates that can be easily modified by researchers without software coding. Further, SpecimenTrack plugs into Investigate(TM), Remedy's translational informatics system that breaks down traditional barriers between sample management, study management, lab information management systems, electronic lab notebooks, and clinical registries.

"We built SpecimenTrack with the recognition that biorepositories cannot stand alone in translational research; they have a central role in enabling connectivity between lab and clinic far beyond a logistical collection of freezers and samples. There is vast potential in both high quality biospecimens and metadata currently locked up in biorepositories around the world that, if properly integrated, can drive benchside research, drug discovery, and clinical outcomes," said Hank Wu, Director of Translational Informatics for Remedy Informatics. "The dual informatics challenges of Translational Research 2.0 are to connect and harmonize traditionally separate data sets and disciplines from the lab, clinic, and biobank, and to enable researchers to conduct deep interpretation of the data with powerful pattern recognition tools. SpecimenTrack coupled with Investigate represents a significant leap forward for biobanks and translational research institutions by giving them powerful tools to maximize the research potential of biospecimens."

Built on the powerful Mosaic(TM) Platform, SpecimenTrack and Investigate are highly configurable research management software that enable researchers to customize data capture forms, workflows, visual queries, dashboards, and data models to their specific needs. Core to the platform is the Mosaic(TM) Ontology, which enables researchers to harmonize and map data from disparate data sources, and to adapt the data model to changing research needs over time by adding new terms and concepts. Together, SpecimenTrack and Investigate enable translational researchers to natively connect biospecimen data into benchside and bedside research.

"As we work to improve researchers' ability to discern and discover patterns in their research it is essential that we provide the tools for them to access all available data so they can gain a true 360-degree view of the biological systems that impact disease," said Gary Kennedy, Founder & CEO of Remedy Informatics. "SpecimenTrack focuses on biobanking but it is also an integral part of the 360-degree whole to help researchers discover the patterns hidden in their data, and ultimately to take giant leaps forward in medical innovation."

SpecimenTrack and Investigate are both currently being implemented by two leading translational research institutions: (1) The Frederick National Laboratory for Cancer Research, a flagship set of ten laboratories of the National Cancer Institute with particular focus on next-generation sequencing and 'omics technologies; and (2) the Oklahoma Medical Research Foundation (OMRF), where integrated lab, biospecimen, and study management will play a key role in research on auto-immune disorders, cancer, Parkinson's disease and many other disorders.